ACADIAN ASSET MANAGEMENT LLC

Position in CRBP — Corbus Pharmaceuticals Holdings, Inc.

CIK 916542 Boston, MA

Position in CRBP

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$350,708

-$670,848 QoQ

Shares Held

37,389

-65.6% QoQ

Ownership

0.193%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#39

of 106 holders

Holding Since

Dec 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $732,389,014 across 168 Biotechnology names. CRBP ranks #102 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	1,664,999	$188,744,286
2	REGN	Regeneron Pharmaceuticals, Inc.	157,440	$98,170,137
3	IMCR	Immunocore Holdings plc	1,209,894	$38,414,134
4	RIGL	Rigel Pharmaceuticals Inc	591,686	$23,146,756
5	EXEL	Exelixis, Inc.	421,444	$22,930,768
6	VRTX	Vertex Pharmaceuticals Inc / Ma	42,122	$20,923,261
7	TBPH	Theravance Biopharma, Inc.	1,174,910	$19,973,470
8	PRTA	Prothena Corp Public Ltd Co	2,010,645	$19,684,214

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$350,708	37,389	-65.6%	Shares	Defined	2026-08-13
2026-03-31	$1,021,556	108,792	+80.8%	Shares	Defined	2026-05-13
2025-12-31	$489,938	60,189	-28.2%	Shares	Defined	2026-02-10
2025-09-30	$1,060,310	83,819	-45.0%	Shares	Defined	2025-11-13
2025-06-30	$1,050,669	152,271	-19.9%	Shares	Defined	2025-08-07
2025-03-31	$1,009,393	190,093	+4338.3%	Shares	Defined	2025-05-21
2024-09-30	$88,358	4,283	-73.0%	Shares	Defined	2024-11-12
2024-06-30	$717,393	15,854	-94.5%	Shares	Defined	2024-08-06
2022-12-31	$31,904	287,430	+208.5%	Shares	Defined	2023-02-14
2022-09-30	$15,373	93,172	0.0%	Shares	Defined	2022-11-14
2022-06-30	$23,479	93,172	-49.4%	Shares	Defined	2022-08-09
2021-12-31	$113,360	184,026	—	Shares	Defined	2022-02-10
No filing history on record for this holder in this stock.